PYC Therapeutics (ASX:PYC) Shares Buyback Ratio %: -24.32 (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:PYC PYC Therapeutics Ltd ASX:PYC
29 GF Score
Price A$2.13
! 2 Warning Signs
View Full Analysis

What is PYC Therapeutics Shares Buyback Ratio %?

PYC Therapeutics ASX:PYC -0.47% 29 Shares Buyback Ratio % is -24.32 as of Aug. 18, 2026. GuruFocus rates ASX:PYC with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. PYC Therapeutics's current shares buyback ratio was -24.32%.

PYC Therapeutics Shares Buyback Ratio % Related Terms

PYC Therapeutics Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for PYC Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PYC Therapeutics Shares Buyback Ratio % Chart

PYC Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.77 0.00 -7.41 -34.97 -24.32

PYC Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.26 -23.53 0.00 -24.32 0.00
ASX:PYC
29GF Score
PYC Therapeutics Ltd ASX:PYC
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PYC Therapeutics Shares Buyback Ratio % Calculation

PYC Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Jun. 2025 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(480.424 - 597.259) / 480.424
=-24.32%

PYC Therapeutics's Shares Buyback Ratio for the quarter that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2025 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Jun. 2025 )
=(597.259 - 597.259) / 597.259
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -24.32 mean?
PYC Therapeutics (ASX:PYC) has a Shares Buyback Ratio % of -24.32 as of Aug. 18, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on PYC Therapeutics and its competitors.
Is PYC Therapeutics' Shares Buyback Ratio % too high?
PYC Therapeutics' current Shares Buyback Ratio % is -24.32. Overall, PYC Therapeutics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does PYC Therapeutics' Shares Buyback Ratio % compare to VRTX and REGN?
PYC Therapeutics' Shares Buyback Ratio % of -24.32 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on PYC Therapeutics and its competitors. PYC Therapeutics's current Shares Buyback Ratio % is -24.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PYC Therapeutics stock overvalued right now?
PYC Therapeutics (ASX:PYC) has a current Shares Buyback Ratio % of -24.32. The current Shares Buyback Ratio % is -24.32. PYC Therapeutics' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For PYC Therapeutics (ASX:PYC), the current Shares Buyback Ratio % is -24.32 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PYC Therapeutics Business Description

Other Exchanges PYCXF:USA
Address 6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.
29GF Score

Get the complete analysis for ASX:PYC

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.13
Price